How many Naked shorts have?
500m plus traded in 2 days?
Float 5/10?

Next year revenues $48m

Gns..short 2.5m plus

5/10,m. Float

500m traded in two days?
5/10 m float,?

Gns
Next. MOASS

Divy and $10 NFT. Coming

Is This In Store For Destiny too:

http://www.pumpsanddumps.com/2014/01/no-cann-do-advanced-cannabis-solutions.html

Ni lerdo ni perezozo! Which means I'm on it like white on rice.

Destiny Media Technologies...The Ultimate Short-Squeeze!

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=96182988

BTH is the one! Next USU in the making:

http://seekingalpha.com/article/1692752-will-blyth-shares-go-parabolic-as-unshorted-float-approaches-zero

CTIC Squeeze!!

YESD .0005 x .0095 Mother Of All Short Squeeze??

APRI...red alert.....low float and over 10% short....25% run this week and company on the verge of announcing their partner for Vitaros.....could be a HUGE squeeze play

AVATQ Looks Like EPIC Squeeze Happening Now!!!!!

watch COHO for short squeeze. 85% shorted on Friday

ITNS WATCH THE SQUEEZE COVER TOMROROW

I really like both plays, pennies are hot right now. You have to play them now or miss them.
regards, buddy

both great pennystockguru articles on VCTY, UWRL will do the same sort of thing. it is same reverse merger play. same ceo. same parent company.

VCTY - just starting to get real interesting imo. Some people are calling for 10 cents next week, some say that is low if we get any rm news. Check out these two articles...

THURSDAY, FEBRUARY 18, 2010
VCTY - Could VCTY Be The Volkswagen of The Pink Sheet Market?
For those of you who do not know, Volkswagen was the recipient of one of the most historic short squeezes of our time. The company, at one point, became the worlds largest by market value... not because it deserved it, but rather because some greedy institutions had shorted the stock to no end, thinking there was no way the stock could rise. Well they were wrong and the stock soared amid a short covering buying frenzy. Could we be seeing a similar scenario with VCTY in the coming days? Could the culprits in this case be greedy Pink Sheet market makers who work under the assumption that these Pink Sheet stock go down, not up?

Obviously the scale and scope of a VCTY short covering rally will pale in comparison to Volkswagen, but then again you never know. When you consider the authorized share count with the amount of shares that have traded recently, it makes you think just how many shares have been sold naked.

Today alone VCTY traded 1/5th of its authorized shares. We've beaten this horse before, but it bears repeating. VCTY has only 105 shares authorized to be traded in the market place. On one day last week the stock traded 88 million shares, or pretty darn close to the entire authorized shares. The following day it traded almost 35 million shares for a two day total of 123 Million shares.

My point is someone is selling shares they don't have. This is the only logical explanation for the volume and price action. The day of reckoning is nearing as the stock is still under some serious accumulation.

Whoever is shorting the stock is betting that the price will fall so they can buy back the phantom shares they've been selling. If the stock does not fall, and continues to rise, these shares will have to be bought back on the open market. Also consider that a rapid rally in the shares will incite a greater need to cover short positions.

This is shaping up to be a promising situation for VCTY longs. It should be interesting to watch this stock trade over the next few days.

& this article……



VCTY - In The Midst Of An Amazing Short Squeeze Penny Stock Guru


VCTY exploded today, most notably late in the session as market makers scrambled to buy whatever shares were left to be had under $.01


Speechless..... That was an email I received from a subscriber today. You read press and rumors about a short squeeze, but to actually witness it coming to fruition is a sight to behold. In all my years of following penny stocks, very rarely do these short squeeze scenarios actually hold water. I think it is fairly obvious that this is exactly what is happening with VCTY.

Consider today when over 40% of the authorized shares traded hands. Or Thursday of last week when almost 90% of the authorized shares traded hands. There simply is not that many shares to justify the volume. Someone is providing liquidity with phantom shares. That is the only logical explanation. If this stock was trading at $.05-$.10 then I may change my stance. But since the price of the stock does not jive with the volume and authorized shares, I have little doubt that market maker NITE is short shares in a big way.

My claims of a short squeeze will be confirmed on Monday when VCTY opens the session over $.01 amid a continuing short covering scenario. It is about time these greedy market makers paid the price for their games. With continued short covering and increasing investor interest VCTY looks poised for some remarkable gains next week.

SKS short position:

SKS $ 7.11
SAKS 0.10
Shares Short 46,917,800
Days To Cover (Short Ratio) 13.6
Short % of Float 44.08 %
Short % Increase/Decrease 13.02 %
Squeeze Ranking™ 1,902
Price % Change (52-wk) 317.30 %
% from 52-Week HIGH ( 7.72 ) -8.58 %
% from 200 DAY MA ( 6.43 ) 9.56 %
% from 50 Day MA ( 6.81 ) 4.22 %
% from 52-Week LOW ( 1.50 ) 78.90 %
Shares Short -Prior Mo 41,514,300
Todays Trading Volume 2,825,519
Avg. Daily Volume 3,453,500
Volume vs. Avg 81.82 %
Market Cap 1,134,569,035
Outstanding Shares 159,573,704
Float 106,441,665
% Held by Insiders 26.40 %
% Held by Institutions 72.70 %
EPS -1.10
PE Ratio
Sector: Services
Industry: Department Stores
SI Record Date 2010-FebA
Exchange NY
All data provided without warranty.

GY short position:

GY $ 4.53
GENCORP 0.00
Shares Short 5,313,700
Days To Cover (Short Ratio) 4.2
Short % of Float 9.16 %
Short % Increase/Decrease 6.94 %
Squeeze Ranking™ 21
Price % Change (52-wk) 53.60 %
% from 52-Week HIGH ( 9.12 ) -101.32 %
% from 200 DAY MA ( 6.12 ) -35.10 %
% from 50 Day MA ( 5.73 ) -26.49 %
% from 52-Week LOW ( 1.83 ) 59.60 %
Shares Short -Prior Mo 4,968,700
Todays Trading Volume 1,323,459
Avg. Daily Volume 1,253,600
Volume vs. Avg 105.57 %
Market Cap 265,005,000
Outstanding Shares 58,500,000
Float 58,019,344
% Held by Insiders 0.80 %
% Held by Institutions 69.10 %
EPS 0.97
PE Ratio 4.70
Sector: Conglomerates
Industry: Conglomerates
SI Record Date 2010-FebA
Exchange NY
All data provided without warranty.

CDIV, in the hole from naked shorting about 30 million shares according to a board ownership count, expect a cover anytime.

ANX-ANX-ANX

I am beginning to buy ACTC. $ 100.00 at a time. It has the potential to be a 1,000 bagger

hey greg.
Happy Holidays to you too.

I haven't been on the ball these days as we get closer to the holidays . I'm kinda in "no mans land", till my kids stop with sporatic half days of school, christmas lunches at work, and general hoopla in the mix.

Have a Great Holiday

Diggler

Happy Holidays Durk, U might want to grab a position in ANX
check it out.
not a short squeeze. bio-stock

The very same one. 19% of float short and only 15% off it's yr. high.

the outdoor/fishing company?

Sup Durk?
we should keep an eye on CAB for a serious short squeeze.
Cabala's

Morning again, ACTC could be getting ready for a move. Big news out. keep an eye on. $15 mil. in funding. Thats a big deal to a small cap that burns about $6 mil per year.
Come in-over? lol


Advanced Cell Technologies Strengthens Balance Sheet Through Completion of Private Placements
Date : 11/16/2009 @ 8:00AM
Source : Business Wire
Stock : Advanced Cell Technology, Inc. (ACTC)
Quote : 0.0982 0.0 (0.00%) @ 2:05AM




Advanced Cell Technologies Strengthens Balance Sheet Through Completion of Private Placements

Advanced Cell Technology, Inc. (“Advanced Cell”, or the “Company”) (OTCBB: ACTC), announced today that it has entered into definitive agreements on three private placements with institutional and other accredited investors under which the Company has received definitive commitments in excess of $15 million. The three investments are expected to provide proceeds sufficient to fund the Company’s general operations and working capital for the next two years. Much of the proceeds will be used to support the Company’s Retinal Pigment Epithelial (RPE) program, which the Company expects to commence later this year through the filing of an IND with the FDA, in addition to funding development of certain other pre clinical programs.

“We are extremely pleased to have negotiated these financings, with the support of existing debt holders, which will leave us sufficiently capitalized well into 2011,” remarked William M. Caldwell IV, CEO of Advanced Cell. “In addition to satisfying our operational and working capital needs, these funds will be integral in advancing our RPE Program through the clinic once we receive FDA clearance to commence clinical activities. Although we will require additional funds for specific development programs, we believe the current funding go a long way to satisfying our general operations and specific research programs into 2011.”

The Company completed the placement of a series of debentures to existing investors in the principal amount of $2,103,000, convertible into common stock at $0.10 per share for which the Company was paid $1,752,000. The Company will be required to redeem the debentures monthly commencing in May 2010, in the amount of 14.28% of the initial principal amount of the Notes, in cash or common stock at the Company’s option. The investors also received warrants to purchase an aggregate of 14,020,000 shares of common stock at an exercise price of $0.108. Further, the investors are obligated to purchase an additional $2,103,000 principal amount of debentures and 14,020,000 warrants within 90 days, at a purchase price of $1,752,000, subject to customary conditions. The investors also received an Additional Investment Right, which terminates in August 2010, and allows the investors to purchase up to $2,200,000 of principal amount of the Company’s convertible notes on the same terms and conditions as the original notes purchased in the offering. If the investors exercise their Additional Investment Right, they will also receive one and one third Class B warrants for each two shares that would be issued if the investors converted the entire portion of the note purchased pursuant to their Additional Investment Right.

The Company also entered into amended agreements with an existing investor. Under the first amended agreement, the Company received gross proceeds of $1,000,000 and issued a secured and collateralized convertible promissory note for $1,200,000. The Company shall pay a one-time interest payment of 10% of the principal of the promissory note which is due on the maturity date of the promissory note, which is in October, 2012. The promissory note is convertible into shares of the Company’s Common Stock at a conversion price of the lesser of (i) $.25 per share or (ii) eighty percent of the average of the three lowest trade prices in the 20 trading days prior to the conversion. Under the second amended agreement, the Company received gross proceeds of $1,000,000 and issued a Secured & Collateralized Promissory Note for $1,000,000. The Company shall pay a one-time interest payment of 12% of the principal of the promissory note which is due on the maturity date of the promissory note, which is in October, 2012. The promissory note is secured by $1,000,000 of a money market fund or other assets of the Investor.

The remaining funding is expected to be provided by Optimus Life Sciences Partners, a private investment fund with offices in New York and California, under which Advanced Cell may sell up to $10 million of 10% non-convertible perpetual preferred stock and warrants to purchase up to approximately 119,000,000 shares of common stock, subject to meeting certain conditions. The warrants are exercisable only to the extent the Company elects to put preferred stock to Optimus. Warrants to purchase common stock equal to 135% of the monies funded by Optimus will be exercisable at the market price of the common stock at the time of each funding. The Company agreed to pay Optimus a commitment fee of 5%, payable in cash or registered shares of common stock (priced at 90% of the then current market price), at the option of the Company.

The Company expects to immediately file a registration statement with the SEC in connection with the Optimus transaction, as well as other recent financings and certain other previously issued securities.

Further information on each of the foregoing transactions can be found in the Form 8-K filed today by the Company with the SEC.

About Advanced Cell Technology, Inc.

I bought into DARA @ .418. They are presenting at a drug conference this thurs.
am watching CRBC AHR IMGG. Boy did I miss IMGG. I radared it @ .42 -3 weeks ago. It ran to 1.95 on fri before it pulled way back to close @ 1.46

what you got your eye on?

thanks gregg. Will do

Durk what up? Keep an eye on CRBC. 11% float short. Huge vol A.H fri. 10 million shares.

Morning Stockibot,
Take a look at the activity on CRBC, it traded 10 mil shares after hrs friday. There is a rather large short position.
I am not quite sure why all the activity, but something is up. And worth keeping an eye on.
Have a look.

What's up Durk D my man?
Where are ya?

Thanks greggor62!

Good to see ya Hwyh. This board talks about potental short squeeze cantidates. But also talking about timing short bets is more than welcome.
Heres a link to a good board. you can navigate from there and find anything you are looking for. Surf1944 is a Straight shooter
http://investorshub.advfn.com/boards/board.aspx?board_id=2754
GLTU

How goes it stockibot?
I'm no pro, but the fundies on BBI warrent the PPS. They are in deep trouble.
But if things turn around??????????? lol Definitly 1 to keep on your watch.
I jumped in DARA yesterday @ .418, Could have a decent run.
GLTU

Opinion from the Short Squeeze pros would be appreciated!

BBI Blockbuster has >30 mil shares short (~25%) with 10.1 Days to Cover on Shares Outstanding of ~122 mil. Trading is getting wound tight and earnings are due next week. Company is working hard to change course. Seems like this could go either way...

http://www.nasdaq.com/aspxcontent/shortinterests.aspx?symbol=BBI&selected=BBI

http://www.shortsqueeze.com/?symbol=bbi&submit=Short+Quote%E2%84%A2

New to board...Is this the best place to start researching potential stocks to short???

If i'm in the wrong place please guide me to where i should go?

GLTA,

--Hwy

Got some penny plays trading sideways. Other than some cit I bought @ a buck a share not much else going on.

Whats up you happy long donged hooker? lol
market getting kicked around here this week. I'm not doing too much. accumulating NEOL and MSBT. both biotech microcaps.
Hope it works out. lol
And you?
have a good one

Thoughts on CIT for a squeezer

Morning Durk, MDGC, fantastic. Whats the story? where is your exit? I see it ran to .11 before pulling back.
I am also in CRBC as well. bank stock, huge vol the last few days.
I'm hoping it explodes to the upside here soon.

Geta having a nice run.

I'm in mdgc @.023. Not a squeeze but don't want to be greedy. Its having a good day.

Morning Durk. It looks like the shorts won out yesterday on AHR. Will be interesting to see if it continues. I wish I coulda gave you a heads up earlier.
I am currently in GETA from .655 we ran to $1.26 yesterday before falling back and closing @ 1.15 They will be announcing the results of phase 3 study for a melonoma drug.
1 to watch today and for the next few is IRDM. I have a feeling they are gonna have a very successful stock offering.
They are starting the bid @ $10.00, but IMO that is cheap for the biggest Satelite company in the world. They just did a R/M into GHQ and moved up from AMEX to NASDAQ. Keep an eye on this one. It could truely be a blockbuster.

Ahr looking sweet.

morning Durk, AHR is a real estate REIT. it looks like that whole sector took off yesterday. I wonder if there will be a continuation.

I am currently playing GETA, from .655. it closed @ .103 yesterday. they have a phase 3 melinoma study that ended yesterday. They will be reporting results in early oct.
Very large vol. and buying here.
Best of luck my man

I'm watching it. Mental resistance at 1.oo

she's pulling back hard. Not enough vol.

Thanks greg. Looking at it now.

Morning Durk, how goes the battle?
AHR may be in a short squeeze here. nice bump yesterday on big vol. Watch it close here today. I'm gonna buy a little if she dips.
GLTU

NPWS Pick your spot here. I think you can get in around 14 ish.
But you want to be in before the close today.
read the board for PR's and news
No need to lie, or pump it to you. I believe this one is the real deal
GLTU

Thanks greg